TY - JOUR
T1 - Oregon's strategy to confront prescription opioid misuse
T2 - A case study
AU - McCarty, Dennis
AU - Bovett, Rob
AU - Burns, Thomas
AU - Cushing, Judy
AU - Glynn, Mary Ellen
AU - Kruse, Senator Jeff
AU - Millet, Lisa M.
AU - Shames, Jim
N1 - Funding Information:
Practitioner education can enhance changes in clinical practice. Taskforce members hosted two trainings and partnered with stakeholders to promote the events. A taskforce member affiliated with the state's medical school facilitated linkages with training resources specifically addressing safer opioid prescribing. Neither the Taskforce nor the Alcohol and Drug Policy Commission had a budget to support prescriber education. Instead, they took advantage of no-cost trainings sponsored by the Substance Abuse and Mental Health Services Administration and a training mandate from the Food and Drug Administration.
Funding Information:
In December 2013, the Alcohol and Drug Policy Commission transitioned responsibility for public and practitioner education, advocacy for take-backs, and promoting access to medication for treatment of opioid dependence to a community-based prevention program—Lines for Life. The former U.S. Attorney for Oregon and current Lines for Life executive director, Dwight Holton, plans five Prescription Drug Summits throughout the state and is expanding the focus to include prescription and non-prescription stimulants as well as prescription and non-prescription opioids. Members of the Prescription Drug Taskforce were instrumental in the hand off to Lines for Life and remain active in the renamed Oregon Coalition for Responsible Use of Medications (OrCRM). The Coalition membership includes business leaders, health care providers, law enforcement and public safety professionals, media experts, addiction prevention and treatment providers, ministers and chaplains, parents, educators, the Governor's office, members of the Prescription Drug Taskforce, young adults and individuals in recovery. The five regional summits will review local data and initiatives, share promising practices, and build community consensus and support. Eventually, the Coalition plans statewide media campaigns on the risks of misusing opioid and stimulant prescriptions. The campaign is supported through a small grant from the state and Lines for Life has applied for a federal Drug-Free Communities award. Partnerships with the Coordinated Care Organizations and regional prevention services provide additional resources.
Publisher Copyright:
© 2014 The Authors.
PY - 2015/1/1
Y1 - 2015/1/1
N2 - Governor John Kitzhaber appointed a Prescription Drug Taskforce to address Oregon's opioid epidemic. This case study reviews the Taskforce's participation in the National Governors Association State Policy Academy on Reducing Prescription Drug Abuse. To address the challenge of the misuse and abuse of prescription opioids, the Taskforce developed a strategy for practice change, community education and enhanced access to safe opioid disposal using stakeholder meetings, consensus development, and five action steps: (1) fewer pills in circulation, (2) educate prescribers and the public on the risks of opioid use, (3) foster safe disposal of unused medication, (4) provide treatment for opioid dependence, and (5) continued leadership from the Governor, health plans and health professionals. Although the story is ongoing, there are lessons for leadership in other states and for public health and medical practitioners throughout the country.
AB - Governor John Kitzhaber appointed a Prescription Drug Taskforce to address Oregon's opioid epidemic. This case study reviews the Taskforce's participation in the National Governors Association State Policy Academy on Reducing Prescription Drug Abuse. To address the challenge of the misuse and abuse of prescription opioids, the Taskforce developed a strategy for practice change, community education and enhanced access to safe opioid disposal using stakeholder meetings, consensus development, and five action steps: (1) fewer pills in circulation, (2) educate prescribers and the public on the risks of opioid use, (3) foster safe disposal of unused medication, (4) provide treatment for opioid dependence, and (5) continued leadership from the Governor, health plans and health professionals. Although the story is ongoing, there are lessons for leadership in other states and for public health and medical practitioners throughout the country.
KW - Prescriber education
KW - Prescription drug monitoring program
KW - Prescription opioids
UR - http://www.scopus.com/inward/record.url?scp=84922804834&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84922804834&partnerID=8YFLogxK
U2 - 10.1016/j.jsat.2014.07.012
DO - 10.1016/j.jsat.2014.07.012
M3 - Article
C2 - 25168199
AN - SCOPUS:84922804834
SN - 0740-5472
VL - 48
SP - 91
EP - 95
JO - Journal of Substance Abuse Treatment
JF - Journal of Substance Abuse Treatment
IS - 1
ER -